Cargando…

A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales:	Bracciolini, GP, Davì, S, Pistorio, A, Consolaro, A, Verazza, S, Lattanzi, B, Filocamo, G, Dalprà, S, Gattinara, M, Gerloni, V, Insalaco, A, De Benedetti, F, Civino, A, Presta, G, Breda, L, Lepore, L, Maggio, C, Garofalo, F, Magni-Manzoni, S, Rigante, D, Buoncompagni, A, Gattorno, M, Malattia, C, Picco, P, Viola, S, Ruperto, N, Martini, A, Ravelli, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184164/ http://dx.doi.org/10.1186/1546-0096-12-S1-P1

Ejemplares similares

PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
por: Negro, G, et al.
Publicado: (2013)

PReS-FINAL-2011: Preliminary validation of a new hybrid measure of muscle strength for juvenile dermatomyositis
por: Marafon, D, et al.
Publicado: (2013)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
por: Consolaro, A, et al.
Publicado: (2008)

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs
por: Consolaro, A, et al.
Publicado: (2013)

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis
por: Meiorin, S, et al.
Publicado: (2008)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)
por: Dalprà, S, et al.
Publicado: (2008)

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?
por: Ullmann, N, et al.
Publicado: (2008)

Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers
por: Raggi, Federica, et al.
Publicado: (2023)

Development and initial validation of a new short and simple Health-Related Quality Of Life (HRQL) Questionnaire for Pediatric Rheumatic Diseases (PRD)
por: Palmisani, E, et al.
Publicado: (2008)

Rapid and sustained effect of anti-TNF treatment in patients with ADA2 deficiency
por: Caorsi, R, et al.
Publicado: (2015)

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis
por: Consolaro, A, et al.
Publicado: (2011)

Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers
por: Bertamino, M, et al.
Publicado: (2011)

Etanercept efficacy in the treatment of chronic isolated inflammatory coxitis
por: Parodi, A, et al.
Publicado: (2008)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
por: Lattanzi, B, et al.
Publicado: (2008)

PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients
por: Verazza, S, et al.
Publicado: (2013)

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
por: Palmisani, Elena, et al.
Publicado: (2007)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
por: Filocamo, G, et al.
Publicado: (2008)

A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis
por: Bava, Cecilia, et al.
Publicado: (2019)

Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 772 patients
por: Verazza, Sara, et al.
Publicado: (2014)

Development and initial validation of a new functional ability tool for juvenile dermatomyositis
por: Varnier, GC, et al.
Publicado: (2011)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
por: Schiappapietra, B, et al.
Publicado: (2011)

PW01-039 – Long-term efficacy of anakinra in SoJIA patients
por: Naselli, A, et al.
Publicado: (2013)

2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis
por: Malattia, C, et al.
Publicado: (2008)

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients
por: Solari, N, et al.
Publicado: (2008)

Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis
por: Corcione, Anna, et al.
Publicado: (2009)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

The diagnostic role of hyperferritinemia in a tertiary care pediatric rheumatology setting
por: Sala, I, et al.
Publicado: (2008)

Intra-articular venous malformations of the knee: a diagnostic challenge
por: Diomeda, Federico, et al.
Publicado: (2021)

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
por: Malattia, C, et al.
Publicado: (2011)

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
por: Malattia, C, et al.
Publicado: (2011)

Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study
por: Consolaro, Alessandro, et al.
Publicado: (2012)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
por: Davì, S, et al.
Publicado: (2008)

Is it worth allowing the presence of morning stiffness in the definition of inactive disease in juvenile idiopathic arthritis?
por: Allegra, Maddalena, et al.
Publicado: (2014)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011)

The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Consolaro, Alessandro, et al.
Publicado: (2018)

Long-term efficacy of IL-1 blockers in PAPA patients
por: Finetti, M, et al.
Publicado: (2015)

PW02-010 - The diagnostic challenge of bone lesions in AID
por: Caorsi, R, et al.
Publicado: (2013)

PReS-FINAL-2237: The diagnostic challenge of osteolytic bone lesions in autoinflammatory diseases: a case report
por: Caorsi, R, et al.
Publicado: (2013)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_n9p286uvjvutjbumtuovrlqesa